About Tasly U.S.
Tasly U.S. is a Healthcare company based in Rockville (United States) founded in 2006, and was acquired by Chongqing Pharmaceutical in June 2020. Pharmaceutical, biologic, and nutraceutical products are provided by Tasly. It operates on a Professional Services model. Tasly U.S. offers products and services including Dantonic® and T89. Its focus areas include Pharmaceuticals and Cardiovascular Drugs. Its legal entity is Tasly Pharmaceuticals, Inc.
Company details
Tasly Pharmaceuticals, Inc., operating as Tasly U.S., is engaged in the development and marketing of pharmaceuticals, biologics, and nutraceuticals. Based in Rockville, Maryland, the company is involved in clinical studies and research for cardiovascular, oncology, liver, stem cell, and immunology solutions. Products like Dantonic and T89 are developed for treating conditions such as chronic stable angina and ischemic heart disease. Collaboration opportunities are explored through global events and partnerships in the biopharmaceutical sector.
- Headquarters Rockville, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website taslyus.com
- Social X Facebook
- Acquired by Chongqing Pharmaceutical (Jun 2020)
- Legal Name Tasly Pharmaceuticals, Inc.
- Investors
- Acquired byChongqing Pharmaceutical
(Jun 2020)
Products & Services of Tasly U.S.
Tasly U.S. offers a comprehensive portfolio of products and services, including Dantonic® and T89.
Botanical drug used for treating angina pectoris effectively.
Drug candidate studied for ischemic heart disease treatment.
Investors in Tasly U.S.
Tasly U.S. has secured backing from 1 investor. Prominent investors backing the company include Chongqing Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provides comprehensive drug discovery services to advance pharmaceutical solutions. | 1950 | cqphar.com | Chongqing, China |
Investor details for Tasly U.S.
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Tasly U.S.
2 dated milestones of Tasly U.S. across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Tasly U.S. is founded.
- Exit Acquired by Chongqing Pharmaceutical.
Web traffic of Tasly U.S.
Websites that share an audience with Tasly U.S. (taslyus.com).
Websites whose visitors overlap most with Tasly U.S.. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| exegipharma.com | 100% | 2.1K | #7,496,544 | View details | |
| vicihealthsciences.com | 96% | 7.9K | #2,765,324 | View details | |
apacpharma.com | apacpharma.com | 96% | – | ||
| supernus.com | 90% | 18.7K | #1,928,683 | View details | |
| avalotx.com | 89% | 4.8K | #3,365,654 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Tasly U.S.
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Tasly U.S. (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Tasly U.S.
Tasly U.S. was founded in 2006.
Tasly U.S. is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Tasly Pharmaceuticals, Inc., operating as Tasly U.S., is engaged in the development and marketing of pharmaceuticals, biologics, and nutraceuticals. Based in Rockville, Maryland, the company is involved in clinical studies and research for cardiovascular, oncology, liver, stem cell, and immunology solutions. Products like Dantonic and T89 are developed for treating conditions such as chronic stable angina and ischemic heart disease. Collaboration opportunities are explored through global events and partnerships in the biopharmaceutical sector.
Tasly U.S. offers Dantonic® and T89.
Tasly U.S. has 1 investor. Key investors include Chongqing Pharmaceutical.
Tasly U.S. operates through Tasly Pharmaceuticals, Inc..
Yes. Tasly U.S. was acquired by Chongqing Pharmaceutical in June 2020.